Irlandia - angielski - HPRA (Health Products Regulatory Authority)

amdipharm limited - tranylcypromine - coated tablet - 10 milligram(s) - monoamine oxidase inhibitors, non-selective; tranylcypromine

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

amdipharm limited - felbinac - gel - 3 percent weight/weight - antiinflammatory preparations, non-steroids for topical use; felbinac

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

amdipharm limited - ibuprofen - gel - 5%w/w percent weight/weight - antiinflammatory preparations, non-steroids for topical use; ibuprofen

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

amdipharm limited - cefotaxime sodium - powder for solution for injection - third-generation cephalosporins; cefotaxime

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

amdipharm limited - cefotaxime sodium - powder for solution for injection - third-generation cephalosporins; cefotaxime

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

amdipharm limited - cefixime trihydrate - film-coated tablet - third-generation cephalosporins; cefixime

Kenia - angielski - Pharmacy and Poisons Board

amdipharm limited amdipharm limited, temple chambers, 3 burlington - hydralazine hydrochloride - coated tablet - 25mg - agents acting on arteriolar smooth muscle:

Kenia - angielski - Pharmacy and Poisons Board

amdipharm limited amdipharm limited, temple chambers, 3 burlington - flumetasone pivalate and clioquinol bp - cream - flumethasone pivalate 0.2% and clioquinol 3% - otological corticosteroids and anti-infectives in

Kenia - angielski - Pharmacy and Poisons Board

amdipharm limited amdipharm limited, temple chambers, 3 burlington - flumetasone pivalate and clioquinol bp - ear drops, solution - flumetasone pivalate 0.02% w/v and clioquinol bp… - ophthalmological and otological preparation:

Unia Europejska - angielski - EMA (European Medicines Agency)

amdipharm limited - zonisamide - epilepsies, partial - antiepileptics, - zonegran is indicated as:monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents, and children aged six years and above.